In this article, we will list the 5 Best Stocks to Invest In on Robinhood for Beginners. Please visit 13 Best Stocks to Invest In on Robinhood for Beginners if you’d like to see an extended list and how we came up with the best stocks on Robinhood.
5. MSCI Inc. (NYSE:MSCI)
Number of Hedge Fund Holders: 62
MSCI Inc. (NYSE:MSCI) is among the best Robinhood stocks.
TheFly reported on March 17 that Raymond James elevated MSCI from an Outperform to a Strong Buy rating, retaining a price target of $710. The firm designated MSCI as its top pick in the information services sector, citing strong sales momentum and minimal exposure to AI-related risks. According to Raymond James, MSCI’s shares trade only slightly above the broader market multiple, presenting a compelling risk/reward opportunity for investors.
Moreover, earlier on March 3, MSCI Inc. (NYSE:MSCI) announced that it expanded its index capabilities across alternative and multi-asset classes by acquiring Compass Financial Technologies, a specialized provider of index services. This acquisition strengthens MSCI’s capacity to design, calculate, and customize complex indexes spanning equities, fixed income, commodities, digital assets, currencies, and derivatives.
The integration enables MSCI to offer sophisticated multi-asset and derivative-inclusive indexes, supporting investors in benchmarking, portfolio construction, and product development. Compass’s advanced platform will accelerate MSCI’s innovation in customized index solutions while maintaining long-term continuity. The transaction terms were not disclosed, and the financial impact is not expected to materially affect MSCI, with Compass’ results reported within MSCI’s Index segment.
MSCI Inc. (NYSE:MSCI) is a financial services company that provides global benchmarks, analytics, and risk management tools, including the widely used MSCI equity indices and ESG products, to help institutional investors make informed investment decisions.
4. Stryker Corporation (NYSE:SYK)
Number of Hedge Fund Holders: 67
Stryker Corporation (NYSE:SYK) is among the best Robinhood stocks.
TheFly reported on March 17 that UBS revised its outlook on SYK and reduced the price target from $400 to $380 while retaining a Neutral rating on the stock.
Additionally, a cyberattack that affected Stryker Corporation’s (NYSE:SYK) operations earlier this month, on March 18, caused delays in some surgeries that depend on custom implants. The business affirmed that efforts are being made to restore the impacted systems and underlined that all products are still safe for patients. Patient-specific treatments had to be rescheduled as a result of the brief outage, which affected the company’s capacity to offer customized inventory. According to a spokeswoman, the disruptions were restricted to situations that needed specialized equipment, and efforts are being made to reduce future delays.
As of March 26, SYK has successfully restored its electronic ordering system and resumed the majority of its manufacturing operations. With most locations and critical production lines back online, production is rapidly increasing. In order to guarantee continuity of treatment for patients and healthcare providers, the business stated that it is giving top priority to the restoration of all vital functions. SYK’s stock has responded favorably to the operational recovery, rising as trust in the company’s capacity to handle the circumstances and uphold its standards for goods and services while finishing the backlog of postponed operations has returned.
Stryker Corporation (NYSE:SYK) is a global medical technology company that designs, manufactures, and sells orthopedic implants, surgical equipment, and medical devices to improve patient outcomes and support hospitals and healthcare providers worldwide.
3. PG&E Corporation (NYSE:PCG)
Number of Hedge Fund Holders: 80
PG&E Corporation (NYSE:PCG) is among the best Robinhood stocks to invest in.
TheFly reported on March 23 that Jefferies downgraded PCG from Buy to Hold and reduced the price target to $19 from $20. The firm expressed skepticism about meaningful wildfire liability reform taking shape for California utilities, noting misalignment between utilities and insurers and uncertainty around political backing for structural changes. With PCG shares having risen roughly 20% since January lows, the stock is seen as increasingly crowded and widely owned, raising concerns about limited upside potential under current market conditions.
In a separate operational development on March 2, PG&E Corporation (NYSE:PCG) announced that it implemented its fifth reduction in electric rates since January 2024 on March 1, marking the third consecutive cut for residential customers receiving both supply and delivery services. Combined with prior adjustments, typical bundled residential rates are now 13% lower than in early 2024, reducing average monthly bills by roughly $25 based on 500 kilowatt-hours of usage.
The March decrease alone lowered standard residential bills by about $5.14 and CARE program bills by approximately $10.37. These reductions reflect completed safety and reliability work costs exceeding new authorized investments and coincide with the introduction of PCG’s Base Services Charge, designed to separate fixed service costs from usage rates, increase transparency, and support affordability, particularly for low-income customers transitioning to clean energy appliances, while keeping total company revenue unaffected.
PG&E Corporation (NYSE:PCG) is a California-based utility company providing electricity and natural gas services to millions of customers, focusing on safe, reliable energy delivery, infrastructure maintenance, and clean energy initiatives across its service areas.
2. Revolution Medicines, Inc. (NASDAQ:RVMD)
Number of Hedge Fund Holders: 85
Revolution Medicines, Inc. (NASDAQ:RVMD) is one of the best Robinhood stocks.
TheFly reported on March 16 that Jefferies initiated coverage of RVMD with a Buy rating and set a price target of $140, up from $88. The firm emphasized the potential of its RAS(ON) platform and positioned itself as a key innovation in oncology. According to Jefferies, the Phase 3 RASolute 302 trial is expected to accomplish its first interim endpoints, indicating a favorable path for the company’s clinical and commercial outlook. Daraxonrasib is recognized as having great possibilities to transform treatment for second-line pancreatic cancer.
Separately, Revolution Medicines, Inc. (NASDAQ:RVMD) declared on March 17 that it will provide important updates from its pipeline of RAS(ON) inhibitors at the 2026 American Association for Cancer Research (AACR) Annual Meeting, which is set for April 17–22 in San Diego.
New Phase 1 data for zoldonrasib in previously treated KRAS G12D mutant non-small cell lung cancer and Phase 1/2 results for daraxonrasib in first-line metastatic pancreatic ductal adenocarcinoma, both as monotherapy and in combination with chemotherapy, are among the nine oral and poster presentations the company has planned. Preclinical research on next-generation catalytic RAS(ON) inhibitors will be covered in other sessions, demonstrating the company’s extensive clinical and discovery efforts to target RAS-driven malignancies and overcome resistance.
Revolution Medicines, Inc. (NASDAQ:RVMD) is a clinical‑stage oncology company developing targeted therapies designed to address difficult‑to‑treat cancers driven by RAS/MAPK pathway mutations using precision‑focused small‑molecule inhibitors.
1. The Boeing Company (NYSE:BA)
Number of Hedge Fund Holders: 114
The Boeing Company (NYSE:BA) is among the best Robinhood stocks.
On March 26, BA secured a $326.05 million firm-fixed-price agreement from the U.S. Army to supply six CH-47F Block II remanufactured cargo helicopters. The contract was awarded following an online solicitation that received a single bid. Each order will include specific work locations and financial information, and the program is anticipated to be finished by August 31, 2031. This contract will be managed and overseen by the Army Contracting Command.
Separately, on March 17, 2026, the Federal Aviation Administration allowed the 777-9 to proceed to the fourth phase of certification testing, marking another significant regulatory milestone for the commercial aviation sector.
This approval allows the aircraft to begin Phase 4A of its five-stage Type Inspection Authorization process, advancing the long-delayed program closer to certification and potential entry into service.
Also, in other news, it was reported on March 19 that NASA is reworking its lunar mission strategy in a way that would significantly shrink BA’s role while giving SpaceX’s Starship a much larger responsibility. Under the revised approach, BA’s Space Launch System would no longer carry Orion close to the moon as originally planned. Instead, Orion would connect with Starship in Earth orbit, and Starship would then transport the crew capsule onward to lunar orbit, making it the primary vehicle for that key portion of the mission.
The Boeing Company (NYSE:BA) is a global aerospace and defense company that designs, manufactures, and services commercial airplanes, military aircraft, satellites, and related systems for customers worldwide.
While we acknowledge the potential of BA to grow, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an AI stock that is more promising than BA and that has 100x upside potential, check out our report about the cheapest AI stock.
READ NEXT: 33 Stocks That Should Double in 3 Years and 15 Stocks That Will Make You Rich in 10 Years
Disclosure: None. Insider Monkey focuses on uncovering the best investment ideas of hedge funds and insiders. Please subscribe to our free daily e-newsletter to get the latest investment ideas from hedge funds’ investor letters by entering your email address below.
